MedCity News May 24, 2022
Raj Indupuri

To achieve diversity goals in research requires a multifaceted approach that makes clinical trial participation easier and uses analytics to help identify the right patients to recruit for a clinical trial.

One of the greatest challenges facing clinical trials today is the timely recruitment of participants, with 40% of cancer trials failing to reach targets for accrual. The reasons for this include, but are not limited to, a lack of awareness and education about the option to be in research trials, limited proximity to research sites, and an inability to participate due to the impact of the protocol requirements on daily life already burdened by disease.

These obstacles have helped energize the decentralized clinical trials (DCT) movement catalyzed by Covid-19,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Big Data, Biotechnology, Clinical Trials, Pharma / Biotech, Technology, Trends
Where do Psychedelics Fit in the Future of Psychiatry?
2024: record year for AI trials
Future Trends for Clinical Trials in 2025 and Beyond
The Future of Clinical Trials: Four Key Trends to Watch in 2025
Small cell lung cancer: Navigating the global clinical trial landscape

Share This Article